These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22997913)

  • 41. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
    Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
    Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A; Łoboz-Grudzień K; Jaroch J
    Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of free radical oxidation in the development of cardiovascular events in chronic renal failure].
    Dzgoeva FU; Gatagonova TM; Dzugkoeva FS; Kochisova ZKh; Kadzaeva ZK; Khamitsaeva OV
    Ter Arkh; 2010; 82(1):51-6. PubMed ID: 20364702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Rahman M; Brown CD; Coresh J; Davis BR; Eckfeldt JH; Kopyt N; Levey AS; Nwachuku C; Pressel S; Reisin E; Walworth C;
    Arch Intern Med; 2004 May; 164(9):969-76. PubMed ID: 15136305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
    Shi HT; Wang XJ; Li J; Song GF; Huang ZY; Guo XY; Guo JJ; Lv ZY; Li HW; Ge JB; Cui J; Qi GM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26553212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B; Fabbian F; Giles M; Johnston A; Baker LR
    Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
    Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications.
    Calò LA; Vertolli U; Pagnin E; Ravarotto V; Davis PA; Lupia M; Naso E; Maiolino G; Naso A
    Life Sci; 2016 Mar; 148():80-5. PubMed ID: 26872982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
    Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
    Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease.
    de Roij van Zuijdewijn CL; Hansildaar R; Bots ML; Blankestijn PJ; van den Dorpel MA; Grooteman MP; Kamp O; ter Wee PM; Nubé MJ
    Am J Nephrol; 2015; 42(2):126-33. PubMed ID: 26382055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study.
    Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
    J Pediatr; 2006 Nov; 149(5):671-5. PubMed ID: 17095341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Specific features of cognitive impairments in patients with predialysis chronic kidney disease].
    Rogova IV; Fomin VV; Damulin IV; Shashkova EV
    Ter Arkh; 2013; 85(6):25-30. PubMed ID: 23866595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2013 Oct; 17(5):730-742. PubMed ID: 23318981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors.
    Haruyama N; Tsuchimoto A; Masutani K; Nagata M; Kitada H; Tanaka M; Tsuruya K; Kitazono T
    Hypertens Res; 2014 May; 37(5):472-7. PubMed ID: 24305517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular hypertrophy and progression of chronic kidney disease.
    Paoletti E
    J Nephrol; 2012; 25(6):847-50. PubMed ID: 22460180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
    Wang CJ; Bao XR; Du GW; Wang Y; Chen K; Shen ML; Wang LZ
    Int Urol Nephrol; 2014 Aug; 46(8):1609-17. PubMed ID: 24839054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
    Kim Y; Cho JS; Cho WK; Yoon HE; Hong YA; Chang YK; Yang CW; Kim SY; Hwang HS
    Int J Cardiol; 2017 Dec; 249():372-376. PubMed ID: 29121742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.